Nabsys, a life sciences company involved in pioneering single-molecule positional sequencing with broad applicability in DNA analysis, has secured $20m in Series D financing round led by new investor Bay City Capital. Nabsys will use the ...
Tags: Nabsys, DNA analysis, Series D financing